Last update 23 Jan 2025

Viravaxx AG

Private Company|
Austria

Overview

Basic Info

Introduction
Viravaxx AG is a privately held company based in Vienna, Austria. Together with the Medical University of Vienna it has developed completely new concepts for preventive and therapeutic vaccines and companion diagnostics for infectious diseases.

Tags

Infectious Diseases
Immune System Diseases
Respiratory Diseases
Prophylactic vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Infectious Diseases4
Immune System Diseases1
Top 5 Drug TypeCount
Prophylactic vaccine4

Related

5
Drugs associated with Viravaxx AG
VVX-004
Target-
Mechanism
Immunostimulants
Active Org.
Viravaxx AG
Originator Org.
Viravaxx AG
Active Indication
HIV Infections
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
RAV vaccines (Viravaxx)
Target-
Mechanism
Immunostimulants
Active Org.
Viravaxx AG
Originator Org.
Viravaxx AG
Active Indication
Respiratory Syncytial Virus Infections
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
COVID-2019 vaccine (Viravaxx)
Target-
Mechanism
Immunostimulants
Active Org.
Viravaxx AG
Originator Org.
Viravaxx AG
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Viravaxx AG
NCT03625934
/ Unknown statusPhase 2
Study to Evaluate the Induction of HBV Virus Neutralizing Antibodies in Healthy Vaccine Naive Adults and Non-responders and in Patients Chronically Infected With HBV Using VVX001
100 Clinical Results associated with Viravaxx AG
Login to view more data
0 Patents (Medical) associated with Viravaxx AG
Login to view more data
100 Deals associated with Viravaxx AG
Login to view more data
100 Translational Medicine associated with Viravaxx AG
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
3
Preclinical
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
RAV vaccines (Viravaxx)
Respiratory Syncytial Virus Infections
More
Preclinical
VVX-004
HIV Infections
More
Preclinical
COVID-2019 vaccine (Viravaxx)
COVID-19
More
Preclinical
VXX-003
Rhinovirus infection
More
Discovery
VVX-001(Viravaxx)
Hepatitis B
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free